Published: 1 May 2025
Committees
Comments on agenda items for the 73rd meeting of the Medicines Classification Committee held on 26 February 2025
The Medicines Classification Committee and the Secretariat wish to thank everyone for their valuable input and feedback.
A total of 41 submissions commenting on agenda items for the 73rd meeting were received. Some of the submissions commented on more than one agenda item. Some parts of the comments have been withheld from publication for the pursuant to the Official Information Act 1982.
Agenda Item 6.1 Lidocaine
Four comments (PDF 1,367KB, 26 pages) were received about this agenda item.
Agenda Item 6.2 Tenofovir disoproxil and emtricitabine
19 comments (PDF 3,944KB, 83 pages) were received about this agenda item.
Agenda Item 6.3 Travel vaccines
Nine comments (PDF 1,894KB, 56 pages) were received about this agenda item.
Agenda Item 6.4 Recombinant Varicella Zoster Virus Vaccine
Five comments (PDF 1,514KB, 31 pages) were received about this agenda item.
Agenda Item 6.5 Allopurinol
17 comments (PDF 1,873KB, 45 pages) were received about this agenda item.
Agenda Item 7.3 Cytisine
Seven comments (PDF 2,122KB, 46 pages) were received about this agenda item.
Agenda Items 8.1c to 8.1k New chemical entities not yet classified in New Zealand, and Agenda Item 8.2a Naratriptan
Two comments (PDF 971KB, 19 pages) were received about these agenda items.
